PerkinElmer (PKI) Tops Q1 EPS by 12c; Offers 2Q EPS/Revenue Outlook, Withdraws FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PerkinElmer (PKI) Announces FDA Provides Emergency Use Authorization for Serological Test to Identify COVID-19 Antibodies
May 5, 2020 9:15 AM EDTPerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUNs (a PerkinElmer company)... More
PerkinElmer (PKI) COVID-19 antibody test receives emergency approval from FDA
May 4, 2020 10:06 AM EDTPerkinElmer (NYSE: PKI) COVID-19 antibody test receives emergency approval from FDA
... More